Michael Charlton Clinical Gastroenterology and Hepatology

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.

The impact of hepatitis E in the liver transplant setting

Masatoshi Kudo Clinical Gastroenterology and Hepatology

Abnormal Liver Tests and Fatty Liver on Ultrasound

The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting Adnan Said, John Williams, Jeremy Holden,

Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

From Fat to Inflammation

Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver

Volume 116, Issue 6, Pages (June 1999)

Flavia D. Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D

Noncardiac Chest Pain Clinical Gastroenterology and Hepatology

Optimum timing of treatment for hepatitis C infection relative to liver transplantation Dr Audrey Coilly, MD, Bruno Roche, MD, Prof Jean-Charles Duclos-Vallée,

The impact of hepatitis E in the liver transplant setting

Leptin, obesity, and liver disease

The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting Adnan Said, John Williams, Jeremy Holden,

Gauree Gupta, Ebbing Lautenbach, James D. Lewis

Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease Kathleen E. Corey, Naga Chalasani Clinical.

The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist Rahima A. Bhanji, Elizabeth J. Carey,

Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity Samyah Shadid, Michael D Jensen Clinical Gastroenterology.

Stephen A. Harrison, MD, FACP Clinical Gastroenterology and Hepatology

Evaluation and Treatment of Obesity

Short-Bowel Syndrome Clinical Gastroenterology and Hepatology

Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD

Diagnosing autoimmune hepatitis in children: Is the International Autoimmune Hepatitis Group scoring system useful? Regan L. Ebbeson, Richard A. Schreiber

Yasuhiko Sugawara, Masatoshi Makuuchi

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis Zobair M. Younossi Clinical.

Abstracts from Around the World

Genetics of Colonic Polyposis

Gilaad G. Kaplan, Daniel B. Gregson, Kevin B. Laupland

Volume 152, Issue 5, Pages e1 (April 2017)

Incidence of Statin Hepatotoxicity in Patients With Hepatitis C

Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Obese or Overweight Patients Sven M.A. Francque, An Verrijken, Ilse Mertens, Guy Hubens,

David J. Hass, Colleen M. Brensinger, James D. Lewis, Gary R

Severe Constipation Clinical Gastroenterology and Hepatology

Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States Ju Dong Yang, Joseph.

Chan Wah Kheong, Nik Raihan Nik Mustapha, Sanjiv Mahadeva

Abnormal Liver Tests and Fatty Liver on Ultrasound

William D. Leslie Clinical Gastroenterology and Hepatology

Nonalcoholic Fatty Liver Disease in Latinos

Effect of Human Immunodeficiency Virus and Antiretrovirals on Outcomes of Hepatitis C: A Systematic Review From an Epidemiologic Perspective Jennifer.

AGA technical review on nonalcoholic fatty liver disease

A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed? Andrew D. Rhim, Michael.

Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg

Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease Veeral Ajmera, MD, MAS, Rohit Loomba,

Issue Highlights Clinical Gastroenterology and Hepatology

Fasiha Kanwal, Jennifer R

Esophageal variceal bleeding: Primary prophylaxis

Björn Lindkvist, Stefan Appelros, Jonas Manjer, Anders Borgström

Volume 141, Issue 4, Pages (October 2011)

Chronic Diarrhea Clinical Gastroenterology and Hepatology

Volume 122, Issue 4, Pages (April 2002)

Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States Zobair M. Younossi, Maria Stepanova

Coagulation in Liver Disease: A Guide for the Clinician

Cytomegalovirus Infection in a Liver Transplant Patient Identified by Endoscopically Severe Duodenal Papillitis Georgios I. Papachristou, Thomas C. Smyrk,

David S. Fefferman, Richard J. Farrell

Masatoshi Kudo Clinical Gastroenterology and Hepatology

Volume 152, Issue 5, Pages e1 (April 2017)

Epithelioid Hemangioendothelioma of the Liver

Robert G. Gish, Nezam H. Afdhal, Douglas T. Dieterich, K

Scott K. Fung, Anna S.F. Lok Clinical Gastroenterology and Hepatology

Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

Rintaro Hashimoto, Akimichi Chonan

Controversies in Liver Transplantation for Hepatitis C

Medical Therapy for Refractory Pediatric Crohn’s Disease

Angiomyolipoma of the Colon

Sanjay K. Murthy, E. Jenny Heathcote, Geoffrey C. Nguyen

Rintaro Hashimoto, Akimichi Chonan

Volume 135, Issue 6, Pages (December 2008)

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Nonalcoholic fatty liver disease: A review of current understanding and future impact Michael Charlton Clinical Gastroenterology and Hepatology Volume 2, Issue 12, Pages 1048-1058 (December 2004) DOI: 10.1016/S1542-3565(04)00440-9 Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 1 Centers of Disease Control estimates of incidence of HCV infection and obesity in the United States, 1982–2000. See http://www.cdc.gov/ Clinical Gastroenterology and Hepatology 2004 2, 1048-1058DOI: (10.1016/S1542-3565(04)00440-9) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 2 Projected relative frequencies of NASH and HCV as indications for liver transplantation (LT). Clinical Gastroenterology and Hepatology 2004 2, 1048-1058DOI: (10.1016/S1542-3565(04)00440-9) Copyright © 2004 American Gastroenterological Association Terms and Conditions